These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5565748)

  • 1. A comparative study of the therapeutic effects of sone 4-chlorinated amphetamine derivatives in depressive patients.
    van Praag HM; Schut T; Bosma E; van den Bergh R
    Psychopharmacologia; 1971; 20(1):66-76. PubMed ID: 5565748
    [No Abstract]   [Full Text] [Related]  

  • 2. 4-Chloramphetamines. Chance and trend in the development of new antidepressants.
    van Praag HM; Korf J
    J Clin Pharmacol New Drugs; 1973 Jan; 13(1):3-14. PubMed ID: 4566121
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution to the question of the central mediation of amphetamine-like effects].
    Frey HH; Magnussen MP
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):115-6. PubMed ID: 4239154
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation into the possible influence of chlorinated amphetamine derivatives on 5-hydroxytryptamine synthesis in man.
    van Praag HM; Korf J; van Woudenberg F
    Psychopharmacologia; 1970; 18(4):412-20. PubMed ID: 4923523
    [No Abstract]   [Full Text] [Related]  

  • 5. Amphetamine and tranylcypromine in an animal model of depression: pharmacological specificity of the reversal effect.
    Katz RJ; Roth KA; Schmaltz K
    Neurosci Biobehav Rev; 1981; 5(2):259-64. PubMed ID: 7196556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coping on amphetamines.
    Paulshock BZ
    N Engl J Med; 1970 Feb; 282(6):346. PubMed ID: 5410841
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonism of psychostimulant 2-phenyl-5,5-dimethyl-tetrahydro-1,4-oxazine hydrochloride (G 130) to central nervous system depressing drugs. Monoamine oxidase inhibitory activity and norepinephrine and serotonin induced changes. Comparison with dL-amphetamine.
    Fanelli O; Mazzoncini V; Trallori L
    Arzneimittelforschung; 1974 Dec; 24(12):2025-9. PubMed ID: 4480283
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trials of an original antidepressive amphetamine, d-l-parachloro-N-methyl-amphetamine or Ro 46861].
    Deniker P; Peron-Magnan P; Eliet-Le Guillou C; Hanus M
    Therapie; 1971; 26(1):219-26. PubMed ID: 5576175
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical perspectives on antidepressant therapy.
    Lehmann HE
    Am J Psychiatry; 1968 May; 124(11):Suppl:12-21. PubMed ID: 4872230
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent knowledge on the biochemical effects of antidepressive agents].
    Rysánek K
    Act Nerv Super (Praha); 1968 Feb; 10(1):85-93. PubMed ID: 4882492
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical application of antidepressant agents in disabled and rehabilitation patients.
    Rosen S; Martorano J
    Arch Phys Med Rehabil; 1965 Nov; 46(11):739-44. PubMed ID: 4221144
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs in the management of depression.
    Johnson MH
    Northwest Med; 1970 Oct; 69(10):780-4. PubMed ID: 5506450
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological properties of racemic and optically active p-chloroamphetamine.
    Nielsen CK; Magnussen MP; Kampmann E; Frey HH
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):428-42. PubMed ID: 6076590
    [No Abstract]   [Full Text] [Related]  

  • 14. The psychiatrist attitudes and therapeutic means when faced with resistant depressions.
    Ginestet D
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Jul; 7(4):194-8. PubMed ID: 4216905
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacologic considerations in the treatment of anxiety and depression in medical practice.
    Goldstein BJ; Brauzer B
    Med Clin North Am; 1971 Mar; 55(2):485-94. PubMed ID: 4926062
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pharmacologic properties and therapeutic effectiveness of the new antidepressant preparation Azaphen].
    Mashkovskii MD; Polezhaeva AI; Avrutskii GIa; Vertozgadova OP; Smulevich AB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(8):1234-8. PubMed ID: 5392529
    [No Abstract]   [Full Text] [Related]  

  • 17. The use and abuse of the psychotropic drugs.
    Enelow AJ
    J Okla State Med Assoc; 1973 Aug; 66(8):355-9. PubMed ID: 4584731
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of treatment with Melitracen (trausabun) in depressive states].
    Wojdyslawska I
    Psychiatr Pol; 1970; 4(4):449-53. PubMed ID: 5472582
    [No Abstract]   [Full Text] [Related]  

  • 19. Influencing the human indoleamine metabolism by means of a chlorinated amphetamine derivative with antidepressive action (p-chloro-N-methylamphetamine).
    van Praag HM; Korf J; van Woudenberg F; Kits TP
    Psychopharmacologia; 1968; 13(2):145-60. PubMed ID: 5678577
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of p-chloroamphetamine on motility in rats after inhibition of monoamine synthesis, storage, uptake and receptor interaction.
    Lassen JB
    Psychopharmacologia; 1974 Jan; 34(3):243-54. PubMed ID: 4819977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.